Our team

We’d love to introduce you to the people who make things happen – our management team, board, medical advisors and investors.

Our team

We’d love to introduce you to the people who make things happen – our management team, board, medical advisors and investors.

Our team

Frans Cromme

CEO

Frans joined ViCentra in May 2019. He has over 20 years of experience in medtech, pharmaceuticals and in vitro diagnostics with roles in marketing, R&D and general management. He has a PhD in oncology as well as an MSc in molecular biology. Frans has lived in a number of countries in Europe and Latin America and loves to climb mountains. Frans’ favourite thing about Kaleido? That it is truly designed to make life easier for people with diabetes, without compromise.

Jorrit Kelderman

CFO

Jorrit is an experienced Chief Financial Officer in the medtech industry who joined ViCentra in December 2018. He has a post-graduate degree in Finance & Control (RC) and MSc in Economics and has worked across the world in Japan, the US and the UK. Jorrit enjoys taking on long-distance cycling challenges, and even tackles his 50k commute by bike. For Jorrit, the feedback from our customers that Kaleido has changed their life is a true motivator.

Sarah Lee

HR Manager

Travel lover Sarah joined ViCentra in 2015 and has been involved with our HR department from an early stage.  She has a 2:1 Honours degree in Law, a four year programme which integrated the LPC and gave her a practical and knowledgeable basis for her future in HR. Sarah’s favourite thing about Kaleido is the motivated, talented and fun people at ViCentra that are able to bring the full Kaleido experience to its customers.

Ruairi Duffy

VP of Research & Development

Ruairi joined ViCentra in 2019 and leads our R&D activities. Prior to this, Ruairi held senior positions in various pharma, medtech and product design organizations in multiple countries. Ruairi has a wealth of experience and a proven track record in medical device product design & development. He is a strong advocate for designing, and bringing to market, simple and intuitive medical products that allows users to live life on their terms: say hello to Kaleido! Outside of work, Ruairi enjoys sport, cooking and classic cars.

Tim Oakes

 CTO and Co-founder

As co-founder, we wouldn’t be where we are today without Tim. Tim is an award-winning design engineer with over seven years of experience in the medical device field, mostly related to drug delivery systems. Having grown up with a father with Type 1 diabetes, Tim has first-hand knowledge of the challenges of trying to fit medical devices into daily life. Tim’s ultimate goal for Kaleido? To keep things simple so Kaleido can make life easier for people with diabetes.

 

Sophia Lam

VP of Quality & Regulatory

Sophia joined ViCentra in 2019 with over 20 years of experience in Quality and Regulatory. Working mostly within the medtech industry, she has significant knowledge on regulatory filings, regulatory inspections and design controls. As a real foody Sophia likes to spend her spare time by going on culinary adventures with friends and family. The best thing about Kaleido for Sophia is that it is an easy to manage, small device which drastically improves the quality of life for people with diabetes.

Michael Webb

VP of Manufacturing

Michael joined ViCentra at the end of 2018. He has a background in engineering and over 15 years of experience in medtech with a focus on Class III medical devices. His experience ranges from New Product Introduction to manufacturing and scaling operations in companies in Australia, the US and now the Netherlands. Michael’s favourite thing about Kaleido? It’s colourful and it offers everyone choice in where and how to wear it to improve their quality of life.

.

Our board

Jan Keltjens

Chairman

As well as chairing the Board of ViCentra, Jan Keltjens currently holds a number of other non-executive Board roles, including Chairman of the Boards of JenaValve Technologies and NightBalance. He was promoted to Vice President of European Marketing for all Cordis divisions in 1998 and Vice President of Worldwide Strategic Marketing for Cordis Cardiology, based in Miami, in 1999. Before joining Cordis, Jan led research and development departments at Unilever and was Managing Director of a group of small high tech companies.

Thijs Cohen Tervaert

Non-executive Board Member

Thijs Cohen Tervaert is a Director at INKEF. Thijs currently also serves on the board of Castor EDC (Netherlands). Prior to INKEF, Thijs was a strategy consultant at the Boston Consulting Group with a focus on health care and technology. He worked on projects for pharmaceutical companies, hospitals and insurers. During a one year secondment, Thijs helped to establish the Amsterdam Health and Technology Institute in 2014. Thijs is a medical doctor and graduated at Leiden University. He has also co-authored several scientific papers.

Anne Portwich

Non-executive Board Member

Anne Portwich, PhD, is a Partner of LSP and has been with the firm since 2001. Anne currently serves on the supervisory boards of Mint Solutions (Netherlands) and Neuravi (Ireland). Previous board positions include Sapiens Steering Brain Stimulation (acquired by Medtronic in 2014), ActoGeniX (acquired by Intrexon in 2015) and Nexstim (IPO in 2014). Anne is a jury member of New Venture, a business plan competition for start-up companies in the Netherlands as well as a member of the evaluation panel for Tekes’ Young Innovative Growth Companies (YIC) funding program in Finland. Anne obtained an MSc in biochemistry from the University of Hanover and received her PhD from the Max Planck-Institute of Marine Microbiology in Bremen.

Jörg Neermann

Non-executive Board Member

Jörg Neermann, PhD, joined LSP as a Partner in 2007 and is based in LSP’s Munich office. Prior to joining LSP, Jörg was the Managing Director of Deutsche Bank’s Venture Capital franchise DVC, where he ran its healthcare investments for more than eight years. Previously, he worked at Atlas Ventures in Germany where he also invested in the healthcare sector. He served as a Director on the supervisory boards of a large number of companies, many of which went public or were sold to larger companies. Among others, Jörg is currently a Director at Probiodrug (a biotech company developing novel Alzheimer’s treatments), EyeSense and Kuros.

Linze Dijkstra

Non-executive Board Member

Linze Dijkstra is a managing partner at Health Innovations and has 20 years of experience in healthcare. Linze sits on the board of ViCentra and is investor director at several of the portfolio companies of Health Innovations, including NovioSense (continuous glucose monitoring), NightBalance (a sleep position trainer for people with sleep apnea) and Stroke2prevent (preventing strokes during cardiac surgery). Prior to Health Innovations, Linze was Director Healthcare at ABN Amro, where he was responsible for the company’s healthcare activities in the Netherlands. Linze also worked as a healthcare-consultant at PricewaterhouseCoopers and holds a Master of Science in Business Administration from the University of Twente.

Remmert Laan

Non-executive Board Member

Remmert (Rem) Laan, is President of Diabetes Insights, LLC, a consulting company specialising in marketing and business development for manufacturers of diabetes drugs, devices and apps and he brings expert knowledge of the diabetes market to ViCentra’s Board . Prior to launching Diabetes Insights in 2015, Rem served as Executive Director of the William Sansum Diabetes Center in Santa Barbara, California. He also holds more than 15 years’ experience in diabetes device commercialisation, including insulin pump products. From 2003 to 2013, Rem served in various capacities with Roche Diabetes Care, including Vice President, External Affairs, North America, and Vice President, Insulin Delivery Systems Global Marketing and Reimbursement.

Our advisors

Dr. G. E. M. G. Storms

Dr. G. E. M. G. (Fred) Storms is one of the Netherlands’ leading authorities on the treatment of diabetes mellitus. Medical Director of the Diabetes Care team at St. Antonius Hospital, Utrecht until his retirement in 2016, Dr. Storms holds a special interest in the medical and technical advancements being made to improve diabetes treatment, and, as such, his work has long focussed on encouraging and supporting such advancements. He has participated in multiple international studies, including AT.LANTUS, PROactive, ONTARGET and EMPA-REG, and contributed to several trials of leading insulin pump therapies.

Our investors

INKEF

INKEF is a venture capital firm based in Amsterdam and focused on the long-term collaboration and active support of innovative companies in the fields of Healthcare, Technology and IT/NewMedia. INKEF was founded in 2010 and currently has €500 million under management.

LSP

LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over €1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.

Health Innovations

Since 2007, Health Innovations has been investing in technology-driven healthcare start-ups, with a focus on early stage investments in Dutch medical device and service companies. Shareholders in their funds include ABN AMRO, Mediq and healthcare insurers Achmea and VGZ. The Dutch government also supports Health Innovations via a seed capital arrangement.

Hello Kaleido...

If you’ve got a question, you’d like to talk something through or you just want to say hey. There’s nothing we like more than a chat. Tell us a bit about you and we’ll whizz a note back as soon as we can!